Overexpression of miR-137 Protects Rat Spinal Cord Neurons From LPS-Induced Inflammation In Vitro Through Targeting RIP3 and Inhibiting IKKβ/NF-κB Signaling Pathway
Acta Poloniae Pharmaceutica - Drug Research · 29.07.2026 · 84 (2) · 239-248
DOI: 10.32383/appdr/225649 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Poloniae Pharmaceutica - Drug Research, online erschienen am 29.07.2026. Verfasst von Shuhe Zhao und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Objective
To investigate the effect of miRNA-137 (miR-137) on the reduction of inflammatory response after spinal cord injury (SCI) in vitro and its molecular mechanism.
Methods
The inflammatory injury model was constructed by treating rat spinal cord neurons with lipopolysaccharide (LPS). The levels of inflammatory factors IL-1β and TNF-α and NF-κB signaling pathway-related proteins p-IκBα and p-p65 were detected by enzyme-linked immunosorbent assay (ELISA) and Western Blot; the expression of miR-137 and receptor interacting protein 3 (RIP3) was detected using qRT-PCR and western blot; the potential binding between miR-137 and RIP3 was predicted on TargetScan database and confirmed by dual luciferase reporter assay.
Results
The expression of miR-137 was downregulated, and RIP3 was upregulated in rat spinal cord neuron cells after LPS treatment, accompanied with increased IL-1β and TNF-α levels. Overexpression of miR-137 could significantly decrease LPS-induced high levels of IL-1β, TNF-α, p-IkBα, and p-p65 in spinal cord neurons. Mechanically, RIP3 was confirmed to be negatively regulated by miR-137 through target binding. Silencing of RIP3 attenuated LPS-induced inflammation as evidenced by descended levels of IL-1β, TNF-α, p-IkBα, and p-p65; whereas overexpression of RIP3 could reverse the inhibitory effect of miR-137 in LPS-induced spinal cord neurons. Conclusion: miR-137 upregulation may inhibit LPS-induced inflammatory injury of spinal cord neurons, at least in part, by targeting RIP3 and modulating the IKKβ/NF-κB signaling pathway. Our findings provide preliminary in vitro evidence supporting miR-137 as a potential therapeutic target for SCI-related neuroinflammation.
Zitieren
APA
Zhao, S., Chen, X., & Duan, Y. (2026). Overexpression of miR-137 Protects Rat Spinal Cord Neurons From LPS-Induced Inflammation In Vitro Through Targeting RIP3 and Inhibiting IKKβ/NF-κB Signaling Pathway. Acta Poloniae Pharmaceutica - Drug Research, 84(2), 239-248. https://doi.org/10.32383/appdr/225649
Vancouver
Zhao S, Chen X, Duan Y. Overexpression of miR-137 Protects Rat Spinal Cord Neurons From LPS-Induced Inflammation In Vitro Through Targeting RIP3 and Inhibiting IKKβ/NF-κB Signaling Pathway. Acta Poloniae Pharmaceutica - Drug Research. 2026;84(2):239-248. doi:10.32383/appdr/225649
BibTeX
@article{Zhao2026,
author = {Zhao, Shuhe and Chen, Xuan and Duan, Yanping},
title = {Overexpression of miR-137 Protects Rat Spinal Cord Neurons From LPS-Induced Inflammation In Vitro Through Targeting RIP3 and Inhibiting IKKβ/NF-κB Signaling Pathway},
journal = {Acta Poloniae Pharmaceutica - Drug Research},
year = {2026},
volume = {84},
number = {2},
pages = {239--248},
doi = {10.32383/appdr/225649}
}
EUVIMED